Prostate Cancer - Results from #120

Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients. March 7, 2023

Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer. March 7, 2023

A Polygenic Risk Score for Prostate Cancer Risk Prediction. March 7, 2023

MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression. March 7, 2023

The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane antigen-targeted imaging. March 7, 2023

LSD1 inhibition disrupts super-enhancer driven oncogenic transcriptional programs in castration-resistant prostate cancer. March 7, 2023

The Optimal Prostate Biopsy in the Era of Multiparametric Magnetic Resonance Imaging March 6, 2023

Stereotactic Body Radiotherapy for Oligometastatic and Oligoprogressive Genitourinary Malignancies: A Work in Progress March 6, 2023

Largest-Ever Genetic Study of Prostate Cancer in Men of African Descent Finds New Risk Factors for the Disease March 6, 2023

First-line Systemic Treatment Options for Metastatic Castration-Sensitive Prostate Cancer: A Living Systematic Review and Network Meta-analysis. March 6, 2023

Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US. March 6, 2023

Patterns of Failure in Men with Radiorecurrent Prostate Cancer: A Post-Hoc Analysis of Three Prospective Ga-68-PSMA PET/CT Imaging Trials. March 6, 2023

Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer. March 6, 2023

Differences in Quality of Life between German and Dutch Patients with Prostate Cancer Treated with Robot-assisted Radical Prostatectomy: Implications for International Multicenter Randomized Controlled Trials. March 6, 2023

Decision Regret in Patients with Localised Prostate Cancer: A Systematic Review and Meta-analysis. March 6, 2023

Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography. March 6, 2023

Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy: A Prospective Randomized Trial. March 6, 2023

Long-term Health-related Quality of Life in Patients on Active Surveillance for Prostate Cancer: A Systematic Review. March 6, 2023

Role of Local and/or Metastasis-directed Therapy in Patients with Hormone-sensitive M1a Prostate Cancer-A Systematic Review. March 6, 2023

Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. March 6, 2023

Page 7 of 1290